Abstract Background and Objectives There is no consensus on the safety and indications of
lateral pelvic lymph node dissection (LPND) for patients with clinical lateral pelvic node …

Aim It is still controversial whether the addition of lateral pelvic lymph node (LPN) dissection
(LPND) to total mesorectal excision (TME) can provide a survival benefit after neoadjuvant …

Background Although lateral pelvic node dissection (LPND) is recommended for rectal
cancer with clinically metastatic lateral pelvic lymph nodes (LPNs), LPNs may respond to …

Abstract Background In 15% to 25% of patients, the lateral pelvic lymph nodes (LPN) are
known to be involved especially with rectal tumors lying below the peritoneal reflection …

Purpose We aimed to evaluate the surgicopathological outcomes of lateral pelvic lymph
node dissection (LPLD) and long-term oncological outcomes of selective LPLD after …

Aim The need or otherwise for lateral pelvic node dissection (LPND) in rectal cancer patients
with clinical lateral pelvic node metastasis (LPNM) after neoadjuvant chemoradiotherapy …

Objective: Lateral pelvic lymph node (LPLN) metastases are an important cause of
preventable local failure in rectal cancer. The aim of this study was to evaluate clinical and …

Background Lateral pelvic node metastasis is one of the major causes of local recurrence in
advanced rectal cancer after preoperative chemoradiotherapy (CRT). However, lateral …

Introduction Intensive local treatment comprising total mesorectal excision (TME) with
selective lateral pelvic lymph node dissection (LPND) after neoadjuvant chemoradiotherapy …

Purpose We aimed to clarify the prognostic impact of lateral pelvic lymph node (LPN)
dissection (LPND) for rectal cancer through a multicenter retrospective study using …